Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
- PMID: 8896563
- DOI: 10.1038/ng1196-320
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
Erratum in
-
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA.Nat Genet. 1996 Dec;14(4):488. doi: 10.1038/ng1296-488. Nat Genet. 1996. PMID: 8944034 No abstract available.
Abstract
Fanconi anaemia (FA) is an autosomal recessive disorder characterized by a diversity of clinical symptoms including skeletal abnormalities, progressive bone marrow failure and a marked predisposition to cancer. FA cells exhibit chromosomal instability and hyper-responsiveness to the clastogenic and cytotoxic effects of bifunctional alkylating (cross-linking) agents, such as diepoxybutane (DEB) and mitomycin C (MMC). Five complementation groups (A-E) have been distinguished on the basis of somatic cell hybridization experiments, with group FA-A accounting for over 65% of the cases analysed. A cDNA for the group C gene (FAC) was reported and localized to chromosome 9q22.3 (ref.8). Genetic map positions were recently reported for two more FA genes, FAA (16q24.3) and FAD (3p22-26). Here we report the isolation of a cDNA representing the FAA gene, following an expression cloning method similar to the one used to clone the FAC gene. The 5.5-kb cDNA has an open reading frame of 4,368 nucleotides. In contrast to the 63-kD cytosolic protein encoded by the FAC gene, the predicted FAA protein (M(r) 162, 752) contains two overlapping bipartite nuclear localization signals and a partial leucine zipper consensus, which are suggestive of a nuclear localization.
Similar articles
-
Positional cloning of the Fanconi anaemia group A gene.Nat Genet. 1996 Nov;14(3):324-8. doi: 10.1038/ng1196-324. Nat Genet. 1996. PMID: 8896564
-
Clinical variability of Fanconi anemia (type C) results from expression of an amino terminal truncated Fanconi anemia complementation group C polypeptide with partial activity.Blood. 1996 May 15;87(10):4424-32. Blood. 1996. PMID: 8639804
-
Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage.Blood. 1998 Apr 15;91(8):2737-44. Blood. 1998. PMID: 9531583
-
[Progress of research on protein composition and gene therapy of Fanconi anaemia - review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Apr;12(2):231-5. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004. PMID: 15157341 Review. Chinese.
-
[Molecular basis of Fanconi's anemia].Klin Padiatr. 1999 Jul-Aug;211(4):192-7. doi: 10.1055/s-2008-1043786. Klin Padiatr. 1999. PMID: 10472548 Review. German.
Cited by
-
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10320-5. doi: 10.1073/pnas.96.18.10320. Proc Natl Acad Sci U S A. 1999. PMID: 10468606 Free PMC article.
-
Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.Mol Med. 1998 Jul;4(7):468-79. Mol Med. 1998. PMID: 9713825 Free PMC article.
-
AMD3100 synergizes with G-CSF to mobilize repopulating stem cells in Fanconi anemia knockout mice.Exp Hematol. 2008 Sep;36(9):1084-90. doi: 10.1016/j.exphem.2008.03.016. Epub 2008 May 20. Exp Hematol. 2008. PMID: 18495331 Free PMC article.
-
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice.Genes Dev. 2003 Aug 15;17(16):2021-35. doi: 10.1101/gad.1103403. Epub 2003 Jul 31. Genes Dev. 2003. PMID: 12893777 Free PMC article.
-
Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.Int J Hematol. 2001 Jul;74(1):33-41. doi: 10.1007/BF02982547. Int J Hematol. 2001. PMID: 11530803 Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous